BioIVT Acquires Fidelis Research

This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.

Abzena strengthens R&D capabilities to support rapid antibody discovery

For further information, images, and interview opportunities, please contact Kristy Harmer at ramarketing: kristy.harmer@ramarketingpr.com | +44 (0)191 222 1242 | ramarketingpr.com | Twitter: @ramarketingpr | Facebook: /ramarketingpr | Linkedin: /ramarketing About Abzena Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.

Zebrafish Disease Models: Accelerating Human Disease Studies and Biomedical Research

Microbiosci Offers Real-time PCR Kits to Support Research Applications in Viral Detection

CRISPR/Cas9 Platform Provides Accurate Gene Knockout Mouse Models for Immunology Research and Drug Discovery

DDA Platform Offers A Wide Range of in Vitro and in Vivo Assays to Cover Early Stage Drug Discovery

Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening

Creative Bioarray Designs Comprehensive Tools and Protocols to Construct Animal Disease Models

Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation

Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant

Scitara announces partnership with Agilent to benefit customers with enhanced digital lab connectivity

Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery

Connect in Pharma provided a platform where key players in European pharma found innovative, patient-centric and sustainable solutions for strengthening the pharmaceutical supply chain.

Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service

Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins

Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Springer Nature Joins PubHive Document Delivery Service

The newly signed document delivery distribution agreement will make Springer Nature article acquisition available to life science companies that license access to PubHive’s scientific workflow management platform

QuBAS 3.0 cuts biostatistics method development time by 80%

Upgraded biostatistics software platform from Quantics offers enhanced flexibility for optimal early-stage development.

MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

Cresset secures significant growth funding from SEP

Cresset, a drug discovery software scaleup, has raised growth capital from SEP to accelerate its product development and international expansion.